Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC Transplantation for HCV-Induced Liver Cirrhosis
NCT02705742Phase 2Unknown
- Sponsor
- Gulhane School of Medicine
- Start
- Jan 2016
- Primary completion
- Jul 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in Liver cirrhosis (LC), hepatitis C (HCV), sponsored by Gulhane School of Medicine. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02705742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705742.